National University of Singapore and Agilent Technologies to Collaborate on Bioanalytical Studies
SINGAPORE, Jan. 27, 2015
National University of Singapore (NUS) and Agilent Technologies Singapore Pte. Ltd. today signed a Memorandum of Understanding (MoU), to promote and develop a novel analytical biochemistry testing standards in pharmaceuticals for use in the clinics.
Under the terms of the MoU, NUS will be given access to the Agilent Proof of Concept Lab, which is equipped with the latest range of bio-analytical equipment, including the high resolution Agilent Liquid Chromatography Quadrupole Time-of-Flight (LC-Q-TOF). The Agilent Proof of Concept Lab is situated within the NUS premise.
“We are happy be working with Agilent. The broad range of technologies available will, ultimately, aid the development of new analytics for personalized patient care,” said Assistant Professor Chester Drum, of the Cardiovascular Research Institute (CVRI), Yong Loo Lin School of Medicine and National University Heart Centre, Singapore (NUHCS) . “Consideration of the patient as an individual, rather than a statistic, is where we will see the next innovations in cardiovascular medicine.”
“As a leading cardiovascular research organization in Singapore, we are delighted to partner with Agilent Technologies to enable the development of cutting-edge analytical biochemistry infrastructure, intellectual property and human capital in Singapore,” said Professor Mark Richards, Director of the CVRI, “This partnership is an excellent example of intelligent extension of our Institute’s technical capacity whilst keeping in step with the needs of industry for mutually constructive and productive partnerships with academic biomedical research groups”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services, and consumables for the entire laboratory workflow. Agilent generated revenues of $4.0 billion in fiscal 2014. The company employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.